MAP kinase and pain
Top Cited Papers
- 25 December 2008
- journal article
- review article
- Published by Elsevier
- Vol. 60 (1) , 135-148
- https://doi.org/10.1016/j.brainresrev.2008.12.011
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Activation of JNK pathway in persistent painNeuroscience Letters, 2008
- Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic painNature Medicine, 2008
- HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor α in spinal cord microgliaGene Therapy, 2007
- Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences, 2007
- Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkineBrain, Behavior, and Immunity, 2006
- Descending serotonergic facilitation of spinal ERK activation and pain behaviorFEBS Letters, 2006
- Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathwayNeuron Glia Biology, 2006
- MAPK signalling: ERK5 versus ERK1/2EMBO Reports, 2006
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic painNature, 2003